Medical/Pharmaceuticals
RemeGen and Innovent Collaborate on Clinical Trials to Evaluate the Potential of RC88 and RC108 Combined with PD-1 Therapy for Advanced Solid Tumors
The partnership focuses on combining novel antibody-drug conjugates RC88 and
RC108 with a PD-1 inhibitor sintilimab for enhanced treatment outcomes
YANTAI, China, July 10, 2023 /PRNewswire/ -- RemeGen Co., Ltd.
2023-07-10 10:24
2335
Kexing Biopharm Makes it into China's Top 20 Biopharmaceutical Enterprises (Blood Products, Vaccines and Insulin) for Two Consecutive Years
SHENZHEN, China, July 7, 2023 /PRNewswire/ -- Kexing Biopharmaceutical (688136.SH) has accomplished the impressive feat of being recognized onJune 27 as one of "China's Top 20 Biopharmaceutical Enterprises" (blood products, vaccines and insulin) for two consecutive years. This prestigious sub-lis...
2023-07-07 19:43
4685
Transcenta Received Approvals from China CDE and South Korea MFDS to Initiate TranStar 301 Global Phase III Pivotal Trial of Osemitamab (TST001)
SUZHOU, China, July 7, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it has received ...
2023-07-07 15:52
2899
MGI's DNBSEQ-T7* Receives Approval for Clinical Use in South Korea
SEOUL, South Korea, July 6, 2023 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced its ultra-high-throughput genetic sequencer DNBSEQ-T7 received the medical device registration certificate from the Korea Ministry of...
2023-07-06 09:00
2814
Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure
Extension of BRII-179 license from VBI Vaccines to global rights bolsters Brii Bio's position to achieve best-in-class HBV functional cure in broad patient populations Company also acquires exclusive rights to PreHevbri®, a clinically differentiated, 3-antigen prophylactic vaccine, from VBI inGr...
2023-07-06 07:25
3050
Brii Biosciences Provides Latest Clinical Development and Corporate Updates
Company extends BRII-179 license to global rights and introduces preventive vaccine, PreHevbri® in Greater China and Asia Pacific markets New data from BRII-835 + PEG-IFN-α study have demonstrated that robust anti-HBs antibody responses at the end of treatment are associated with sustained HBsA...
2023-07-06 07:19
3029
Sirnaomics Establishes a Strategic Partnership with EDIRNA Inc., an RNA-Editing Therapeutic Company
HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, July 5, 2023 /PRNewswire/ --Sirnaomics Ltd. (the "Company", stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced...
2023-07-05 23:07
2650
apoQlar secures funding led by YZR Capital, revolutionizes surgical care through partnerships
HAMBURG, Germany, July 5, 2023 /PRNewswire/ -- apoQlar, a pioneering healthtech company, has successfully secured a funding round led by venture capital firm YZR Capital, specializing in health tech investments. This significant investment validates the potential of apoQlar's advanced augmented r...
2023-07-05 13:00
2615
GILEAD SCIENCES AND IAS - THE INTERNATIONAL AIDS SOCIETY - HONOUR HEALTHCARE PROVIDERS GLOBALLY WHO CHAMPION STIGMA-FREE HIV SERVICES
— The 2023 Me and My Healthcare Provider (MMHCP) campaign, supported by Gilead for the second year running, honours frontline workers providing exemplary inclusive, stigma-free HIV services in Brazil,Hong Kong, Mexico and Taiwan — — The IAS also debuts a novel, stigma-free services "cookbook" for...
2023-07-05 11:00
2544
VentureBlick Secures US$2.6M for First Two Startups, Unveils Super Incubator Model for Medtech Innovation
SINGAPORE, July 5, 2023 /PRNewswire/ -- VentureBlick, a global venture platform for healthcare innovation, announces the successful closure of its first two deals, securing a total ofUS$2.6 million for two startups despite a challenging funding environment. This achievement is a testament of Vent...
2023-07-05 10:00
3029
Chula Researchers Find "Extreme Stress and Depression" Chemicals in Sweat and Successfully Test Firefighters' Mental Health for the First Time!
BANGKOK, July 4, 2023 /PRNewswire/ -- Further to the success of the COVID-19 sweat test, Assistant Professor Dr.Chadin Kulsing, Department of Chemistry, Faculty of Science, in collaboration with Dr. Patthrarawalai Sirinara, MD, MPH Department of Preventive and Social Medicine, Faculty of Medicin...
2023-07-04 16:59
3002
PharmaLedger Reaches 30+ Members Demonstrating the Ecosystem Trend in Digital Health
BASEL, Switzerland, July 4, 2023 /PRNewswire/ -- The PharmaLedger Association,
a pioneering nonprofit organization dedicated to fostering a secure and reliable
Digital Trust Ecosystem
2023-07-04 10:30
2544
AFTER FIVE YEARS OF SUCCESSFUL EXPERIENCE INTERNATIONALLY, BIOCON BIOLOGICS' HULIO® BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES
BRIDGEWATER, N.J. and BENGALURU, India, July 3, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, today announced that HULIO® (adalimumab-fkjp) injection, a biosimilar to Humira® (adalimumab), is now available to patients inthe United States after five years of experien...
2023-07-04 01:22
2386
Lumos Receives US FDA Clearance for FebriDx®
MELBOURNE, Australia, July 3, 2023 /PRNewswire/ -- Lumos Diagnostics (ASX: LDX), ("Lumos" or the "Company") a leader in rapid, point-of-care (POC) diagnostic technologies, is pleased to announce that it has received clearance from the US Food and Drug Administration (FDA) to market its FebriDx® r...
2023-07-03 21:50
2621
Henlius Forecasts Profit in 1H 2023
Spurring a Seamless R&D, Manufacturing, and Commercialisation Positive Cycle SHANGHAI, July 3, 2023 /PRNewswire/ -- Henlius (2696.HK) released a positive profit forecast. Based on the preliminary assessment of the unaudited comprehensive management accounts for the six months endedJune 30, 2023, ...
2023-07-03 18:59
4482
Singapore Hosts the 25th World Congress of Dermatology - The First in Southeast Asia, Drawing Over 11,000 Delegates to Discuss New Developments in Skin Research and Treatments
Themed 'Dermatology Beyond Borders', WCD2023 is one of the largest international medical conventions in the region, and is set to gather over 11,000 local and foreign delegates, including clinicians, scientists, other health-care professionals and industry partners across 130 countries to unveil ...
2023-07-03 18:29
2674
SHL Medical acquires 100% of the shares in Swiss company LCA Automation
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider. The acquisition is SHL Medical's response to the growing market demand for drug delivery solutions and will support its manufacturing operations globally, especially the upcomingSwiss man...
2023-07-03 17:00
2396
Alma, a Sisram Medical company, is establishing a direct operation in China after completing the acquisition of PhotonMed
HONG KONG, July 3, 2023 /PRNewswire/ -- Alma, the world leader and innovator in providing energy-based medical and aesthetic solutions and a wholly-owned company by Sisram Medical (1696.HK), announced today that it has completed the acquisition of PhotonMed International Ltd ("PhotonMed"), the le...
2023-07-03 15:48
4518
Fair Play Menarini International Awards, the 2023 edition starts with the talk show "The Champions tell their Stories" in Piazza della Signoria, Florence
FLORENCE, Italy, July 3, 2023 /PRNewswire/ -- The countdown has begun to the XXVII edition of the Fair Play Menarini International Awards. Tomorrow, Monday, July 3rd, the 2023 edition of the event, dedicated to the sporting values of ethics, fair play and respect, will officially begin in the cit...
2023-07-03 09:31
2435
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma
ROCKVILLE, Md. and SUZHOU, China, July 3, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2023-07-03 08:00
4332
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8873
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7709